System and method of measuring changes in arterial volume of a limb segment

- Angiologix, Inc.

A medical diagnostic device performs diagnostics for assessing the ability of the arteries to respond to an increase in blood flow. The medical diagnostic device determines relative changes in arterial volume of the limb segment during a time period after a stimulus relative to the arterial volume of the limb segment during a baseline period using the amplitudes or other portions of the component pulse waves (such as early systolic components) of volume pulse waves during the baseline period and after the stimulus.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. application Ser. No. 12/483,930, filed Jun. 12, 2009 now U.S. Pat. No. 8,057,400, which claims the benefit of U.S. Provisional Application No. 61/177,341, filed May 12, 2009, which are incorporated herein by reference.

FIELD

The present invention relates generally to assessing changes in the arterial volume of a limb segment.

BACKGROUND

Cardiovascular disease is a leading cause of morbidity and mortality. It has been shown that the early stages of cardiovascular disease can be diagnosed by assessing the ability of the arteries to dilate in response to an increase in blood flow. The degree of arterial dilation in response to an increased blood flow correlates with the severity of cardiovascular disease.

Endothelial cells constitute the innermost lining of blood vessels and produce nitric oxide, which is the predominant vasodilator in the arterial system. An increase in blood flow results in increased shear stress at the surface of endothelial cells and initiates a signaling pathway that results in phosphorylation and activation of nitric oxide synthase, and increased production of nitric oxide. In addition to acting as a potent vasodilator, endothelium-derived nitric oxide inhibits many of the initiating steps in the pathogenesis of atherosclerotic cardiovascular disease, including low-density lipoprotein uptake, white cell adhesion to the vessel wall, vascular smooth muscle proliferation, and platelet adhesion and aggregation.

Brachial artery flow-mediated dilation serves as a measure of the bioavailability of endothelium-derived nitric oxide in patients, and it has been used extensively in large clinical studies to non-invasively detect endothelial dysfunction of the conduit artery.

Several invasive and non-invasive techniques have been developed to evaluate endothelial function. Invasive techniques, which involve intra-coronary or intra-brachial infusions of vasoactive agents, are considered to be the most accurate for the detection of endothelial dysfunction. Due to their highly invasive nature, the use of such techniques is limited and has led to the development of several non-invasive techniques. The ultrasound imaging of the brachial artery is the most commonly employed non-invasive technique for the assessment of the vasomotor response. See, for example, Mary C. Corretti et al. J. Am. Call. Cardiol. 2002; 39:257-265, which is incorporated herein by reference in its entirety. It utilizes continuous electrocardiogram (EKG) gated two-dimensional ultrasound imaging on the brachial artery before and after induction of arterial dilation by five-minute cuff occlusion of the arm. The ultrasound imaging technique is mostly used to assess (1) the changes in the diameter of the brachial artery induced by administration of vasoactive drugs; and (2) flow-mediated dilation, which follows an occlusion of the brachial artery via inflating a cuff around the limb. Once the cuff is released, the blood flow causes shear stress on the endothelium, which, in turn, produces vasoactive substances that induce arterial dilation. The increase in the diameter of the brachial artery in healthy people is higher than that in patients with endothelial dysfunction. However, even in healthy people, the magnitude of the arterial dilation is not sufficient to be reliably determined by the ultrasound imaging technique. A trained and experienced operator is essential in obtaining meaningful data with the ultrasound imaging technique. This difficulty limits the testing of arterial dilation with the ultrasound imaging technique to specialized vascular laboratories.

Most of the existing techniques do not quantify the amount of stimulus delivered to the endothelium nor do they account for other sources of nitric oxide such as the nitric oxide transported and released by the blood cells in response to hypoxemia induced by the temporary occlusion of the brachial artery. It has been shown that these factors can significantly affect the amount of flow-mediated dilation and, therefore, inject additional variability into the test results obtained with equipment that does not account for such factors.

U.S. Pat. No. 6,152,881 (to Rains et. al.), which is incorporated herein by reference in its entirety, describes a method of assessing endothelial dysfunction by determining changes in arterial volume based on measured blood pressure using a pressure cuff. The pressure cuff is held near diastolic pressure for about ten minutes after an artery occlusion until the artery returns to its normal state. The measured pressure during this time is used to determine the endothelial function of the patient. The extended period of applying cuff pressure to the limb affects circulation, which in turn impacts the measurements.

U.S. Pat. No. 7,390,303 (to Dafni), which is incorporated herein by reference in its entirety, describes a method of assessing arterial dilation and endothelial function, in which the relative changes in the cross sectional area of a limb artery are assessed using a bio-impedance technique to monitor cross-sectional area of a conduit artery. Measurements of bio-impedance are difficult to perform. Since bio-impedance measurements involve applying electricity to the skin of the patient, such measurements are poorly tolerated by patients due to skin irritation. Further, the measured signals vary greatly.

U.S. Pat. No. 7,074,193 (to Satoh et al.) and U.S. Pat. No. 7,291,113 (to Satoh et al.), which are incorporated herein by reference in their entirety, describe a method and apparatus for extracting components from a measured pulse wave of blood pressure using a fourth order derivative and an n-th order derivative, respectively.

A clinical need exists for a system and method that are inexpensive, easy to perform, non-invasive, well tolerated by patients, and provide an indication of the ability of arteries to respond to an increase in blood flow.

SUMMARY

A method and diagnostic system provide for assessing changes in arterial volume of a limb segment of a mammal. In one aspect, the diagnostic system determines amplitudes of component pulse waves of detected volume pulse waves of a limb segment detected during a baseline period to determine a baseline arterial volume of the limb segment. The diagnostic system determines amplitudes of component pulse waves of detected volume pulse waves of the limb segment detected during a time period after a stimulus has been applied to the mammal to induce a period of change in the arterial volume of the limb segment. The diagnostic system determines relative change in arterial volume of the limb segment during the time period after the stimulus relative to the arterial volume of the limb during the baseline period from the amplitudes of the component pulse waves of the detected volume pulse waves at baseline and after the stimulus.

In another aspect, the diagnostic system determines relative change in arterial volume by comparing the amplitudes of the component pulse waves of volume pulse waves at baseline and after the stimulus.

In another aspect, the component pulse wave is an early systolic component. In another aspect, the diagnostic system determines relative change in arterial volume by comparing maximum amplitudes of the early systolic components of the volume pulse waves during the baseline period and maximum amplitudes of the early systolic components of the volume pulse waves after the stimulus.

In another aspect, the diagnostic system monitors the limb segment to detect the detected volume pulse waves of the limb segment during the baseline period, and monitors the limb segment to detect the detected volume pulse waves of the limb segment during an after-stimulus period.

The features and advantages described in the specification are not all inclusive and, in particular, many additional features and advantages will be apparent to one of ordinary skill in the art in view of the drawings, specification, and claims. Moreover, it should be noted that the language used in the specification has been principally selected for readability and instructional purposes, and may not have been selected to delineate or circumscribe the inventive subject matter.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a pictorial diagram illustrating a diagnostic system in accordance with the present invention.

FIG. 2 is a block diagram illustrating the diagnostic system of FIG. 1.

FIG. 3 is a flow chart illustrating an operation of arterial volume change assessment of the diagnostic system of FIG. 1.

FIG. 4 is a timing diagram illustrating pressure applied to a limb during baseline testing and analysis and after-stimulus testing and analysis of FIG. 3 with an occlusion providing a stimulus.

FIG. 5 is a timing diagram illustrating amplitudes of early systolic components of pulse waves measured during a baseline period and an after-stimulus period of FIG. 4.

FIG. 6 is a graph illustrating correlation between the normalized increases in amplitudes of early systolic components of pulse waves of a segment of an arm as measured in some embodiments and the increases in diameter of the brachial artery measured via ultrasound imaging of the brachial artery.

FIG. 7 is a timing diagram illustrating blood flow and systolic pressure after release of the occlusion in FIG. 4.

FIGS. 8a and 8b are timing diagrams illustrating, in an expanded view, measured cuff pressure oscillations of a limb during one inflation/deflation cycle of FIG. 4 before occlusion and during one cycle of FIG. 4, respectively, after occlusion of blood vessels in the limb.

FIG. 9 is a timing diagram illustrating pressure applied to the limb during the baseline testing and analysis and after-stimulus testing and analysis of FIG. 3 with an oral administration of nitroglycerin providing a stimulus.

FIG. 10 is a timing diagram illustrating amplitudes of early systolic components of pulse waves measured during a baseline period, a stimulus period, and a after-stimulus period of FIG. 9.

FIG. 11 is a flow chart illustrating one embodiment of the operation of arterial volume change assessment of FIG. 3.

FIG. 12 is a flow chart illustrating one embodiment of an operation of determining amplitude of the arterial volume change assessments of FIGS. 3 and 11.

FIG. 13 is a timing diagram illustrating a measured pulse wave for a healthy person.

FIG. 14 is a timing diagram illustrating a measured pulse wave for a patient with cardiovascular disease.

FIG. 15 is a flow chart illustrating one embodiment of an operation of determining changes in arterial volume of the operations of FIGS. 3 and 11.

 DETAILED DESCRIPTION

A preferred embodiment of the present invention is now described with reference to the figures where like reference numbers indicate identical or functionally similar elements. Also in the figures, the leftmost digits of each reference number correspond to the figure in which the reference number is first used.

FIG. 1 is a pictorial diagram illustrating a diagnostic system 100 in accordance with the present invention. The diagnostic system 100 comprises a diagnostic device 102, a diagnostic computer 104, a cuff 106, a Doppler transducer 108, and an oxygen saturation (StO2) sensor 110.

As used herein, the volume pulse waves are oscillations in the blood pressure between the systolic and the diastolic pressures of arteries. The diagnostic system 100 detects the volume pulse waves and performs diagnostics for assessing arterial volume changes of a limb segment based on the detected pulse waves. In some embodiments, the volume pulse wave includes a composite pulse wave formed of a superposition of a plurality of component pulse waves. The component pulse waves partially overlap and the arterial pulse wave shape or contour is formed by the superposition of the component pulse waves. The component pulse waves may include, for example, an incident systolic wave (also called early systolic wave), a reflected wave (also called late systolic wave), and other waves. The diagnostic system 100 measures amplitudes of components of arterial volume pulse waves as a way of monitoring the changes in arterial volume of the limb segment after a stimulus. While it may be easier to measure the amplitude of the whole arterial volume pulse wave, the timing of the component pulse waves shifts throughout the testing procedure and changes the shape of the pulse wave. In some embodiments, the diagnostic system 100 measures amplitude of a physiologically significant component (such as a component pulse wave) of the volume pulse wave to assess the changes in arterial volume of the limb segment. The diagnostic system 100 may use any component pulse wave of the detected volume pulse wave or portion thereof (such as maximum, inflection point, or amplitude at a fixed time of the component pulse wave), any portion of the volume pulse wave (such as maximum, inflection point, or amplitude at a fixed time of the volume pulse wave), or a combination thereof for the diagnostics for assessing arterial volume changes. As an illustrative example, the operation of the diagnostic system 100 is described herein in terms of the early systolic wave.

In use, the cuff 106 is disposed around a limb 120 so that when the cuff 106 is inflated, the cuff 106 constricts a segment of the limb 120. It is understood by those skilled in the art that the measurements of the changes in the arterial volume of a limb segment described herein are not measuring the volume changes of only a single artery in the limb 120, but are measuring the volume changes in substantially all arteries in the segment of the limb 120 that is being constricted. Although the volume changes measurements and the physiology thereof are described for a single artery, one skilled in the art will recognize that the invention is not restricted to a single artery and that the volume changes measurements are of all or substantially all arteries in the segment of the limb being measured. The limb 120 may be any limb or digits thereof, but for the sake of simplicity, the limb 120 is described as an arm, and the artery that is being evaluated is described as the brachial artery. In some embodiments, the limb 120 is a leg and the artery is a femoral artery. Although the diagnostic system 100 is described for use on a human being, the invention is not so limited. The diagnostic system 100 can be used on other mammals.

The diagnostic computer 104 provides control signals to the diagnostic device 102 and receives information and detected data from the diagnostic device 102.

The diagnostic device 102 provides air to and releases air from the cuff 106 via a tube 112 of the cuff 106. The diagnostic device 102 may control, detect and monitor the air pressure in the tube 112. In some embodiments, a gas other than air, or a liquid, such as water, may be used in the cuff 106, the tube 112, and the pneumatic module 202 (see FIG. 2). In some embodiments, the cuff can be an electrically-controlled elastomer or a mechanically-controlled material.

Although the diagnostic system 100 is described herein as applying a pressure via the cuff 106 to the limb 120 to occlude an artery 122 as a stimulus of the endothelium as blood flows into the artery 122 after release of the occlusion, other forms of stimuli may be provided. In various embodiments, the stimulus of the endothelium comprises a mechanical stimulation, a thermal stimulation, a chemical stimulation, an electrical stimulation, a neurological stimulation, a mental stimulation or a stimulation via physical exercise, or any combination thereof, to induce a change in arterial volume of the limb segment. The stimuli are well known and some of them induce formation of nitric oxide by the endothelial cells lining the walls of the arteries. In some embodiments, the stimulus to the endothelium can also be delivered in any way that transiently and locally increases the blood flow and shear stress at the arterial wall. For instance, this can be achieved by applying ultrasound waves such that it creates turbulence inside a major artery. The chemical stimulation may be, for example, a vasoactive agent, such as an oral administration of nitro glycerol, or an intra-brachial infusion of acetylcholine.

The diagnostic device 102 provides control signals to and receives measurement signals from the Doppler transducer 108 and the oxygen saturation (StO2) sensor 110. The Doppler transducer 108 and the oxygen saturation (StO2) sensor 110 are used in some embodiments for the purpose of quantifying the amount of a vasodilatory stimulus, such as a transient occlusion of the arteries of the limb segment.

The Doppler transducer 108 is disposed on the limb 120 and adjacent to the artery 122 in the limb 120 and distal or proximal from the cuff 106 for measuring blood flow velocity in the artery 122 using a Doppler process. The Doppler transducer 108 may be any conventional Doppler transducer designed to measure blood flow velocity in a conduit artery. In some embodiments, the diagnostic system 100 does not include a Doppler transducer 108.

The oxygen saturation (StO2) sensor 110 is disposed on the limb 120 and distal from the cuff 106 for measuring oxygen levels in the tissue of the limb to determine the extent to which hemoglobin in the tissue is saturated with oxygen. The oxygen saturation (StO2) sensor 110 may be any conventional StO2 sensor. In some embodiments, the diagnostic system 100 does not include an oxygen saturation (StO2) sensor 110.

Although the Doppler transducer 108 and the oxygen saturation sensor 110 are described herein as an apparatus to quantify the amount of stimulus via occlusion, other apparatus to quantify the amount of vasoactive stimuli may be provided.

Although the diagnostic computer 104 is described herein as performing the control, computation, and analysis of the diagnostic system 100, the invention is not so limited. The diagnostic device 102 may include a processor or microcontroller for performing any or all of the operations described herein as being performed by the diagnostic computer 104.

Although the diagnostic computer 104 is described herein as being local to the blood diagnostic device 102, the diagnostic computer 104 may be coupled to the diagnostic device 102 through a communication line, system, or network, such as the Internet, wireless, or landline. For example, the operation of the diagnostic device 102 may be done near the patient while the diagnostic computer 104 may remotely process the data.

FIG. 2 is a block diagram illustrating the diagnostic device 102. The diagnostic device 102 comprises a pneumatic module 202, a pressure detector 204, a Doppler transducer system 206, an oxygen saturation (StO2) sensor system 208, and an interface 210. The pneumatic module 202 controls pressure in the cuff 106 in response to control signals from the diagnostic computer 104. The pneumatic module 202 comprises a pump 222 (e.g., an air pump) for pressurizing air, a reservoir 224 for storing the pressurized air, and a pressure controller 226 for controlling the release of air via the tube 112 into the cuff 106.

The pressure detector 204 comprises a pressure sensor electronics system 228 for controlling a pressure sensor 230, which senses pressure in the cuff 106 via the tube 112. The pressure sensor 230 detects pressure oscillations in the cuff 106 resulting from pulse waves in the artery 122. In some embodiments, the pressure sensor 230 is disposed in the cuff 106 or in the tube 112. In some embodiments, the pressure sensor 230 is a plethysmography sensor, such as a reflective photo-plethysmography sensor.

The interface 210 communicates control signals and information signals between the diagnostic computer 104 and the pneumatic module 202, the pressure detector 204, the Doppler transducer system 206, and the oxygen saturation (StO2) sensor system 208. The interface 210 may include a processor or microcontroller for performing any or all of the operations described herein.

The Doppler transducer system 206 communicates with the Doppler transducer 108 for measuring blood flow velocity in the artery 122. In some embodiments, the diagnostic computer 104 commands the Doppler transducer system 206 to measure blood flow velocity through the artery 122 after the cuff pressure has been released to assess the amount of stimulus delivered via shear stress to the artery 122.

In some embodiments, the diagnostic computer 104 may include test data of blood velocity and may use such test data to quantify the amount of the post-occlusion stimulus in a patient. The diagnostic computer 104 may use this data as part of the assessment of changes in the arterial volume of the limb segment described herein.

The oxygen saturation (StO2) sensor system 208 communicates with the oxygen saturation (StO2) sensor 110 to measure oxygen levels in the tissue for determining the extent to which the hemoglobin in the blood of the tissue is saturated with oxygen.

In some embodiments, the diagnostic computer 104 may include test data of oxygen saturation and may use such test data to standardize the degree of limb ischemia among the test subjects, and quantify the amount of the post-occlusion stimulus in a particular patient. The diagnostic computer 104 may use this data as part of the assessment of changes in the arterial volume of the limb segment described herein.

FIG. 3 is a flow chart illustrating an operation of arterial volume change assessment of the diagnostic system 100. Before operating the diagnostic system 100, the cuff 106 is placed around the limb 120 (e.g., arm) of the patient. The test is started with an entry on the diagnostic computer 104 in any well known manner such as keystrokes on a keyboard (not shown) or movement of a cursor and selection of a screen button via a mouse (not shown). In response to an initiation of the diagnostic command, the diagnostic computer 104 assesses changes in the arterial volume of a segment of the limb 120. The diagnostic computer 104 performs baseline testing and analysis (block 302) during a baseline period 402 (see FIG. 4 below). In some embodiments, the diagnostic system 100 detects and analyzes volume pulse waves of a segment of the limb 120 during the baseline period in which no stimulus is applied to the patient. In some embodiments, the analysis of the volume pulse waves includes determining amplitudes of the detected volume pulse waves to calculate a baseline arterial volume of the segment of the limb 120. One embodiment of the baseline testing is described below in conjunction with FIG. 4.

A stimulus is applied to the patient to induce a period of change in arterial volume of the segment of the limb 120 (block 304) during a stimulus period 404 (see FIG. 4 below). In some embodiments, the diagnostic computer 104 commands the pneumatic module 202 to pressurize the cuff 106 to a level sufficient to occlude the artery 122. In some embodiments, the cuff 106 is inflated to a pressure above systolic for a period of time sufficient to induce change in arterial volume of the segment of the limb 120 after releasing the cuff pressure.

The diagnostic computer 104 performs after-stimulus testing and analysis (block 306) during an after-stimulus period 406 (see FIG. 4 below). In some embodiments, the diagnostic system 100 detects and analyzes volume pulse waves of a segment of the limb 120 after the stimulus, such as a predetermined time after either starting or terminating the application of the stimulus. In some embodiments, the analysis of the volume pulse waves includes determining amplitudes of early systolic components of the detected volume pulse waves to calculate an after-stimulus arterial volume of the segment of the limb 120. One embodiment of the after-stimulus testing is described below in conjunction with FIG. 4. The analyses of blocks 302 and 306 may be performed separately from the testing and at a later time.

The diagnostic computer 104 performs an arterial volume change assessment (block 308). In some embodiments, the diagnostic computer 104 calculates the relative change in arterial volume of the limb 120 during the after-stimulus time period 406 (see FIG. 4) relative to the arterial volume of the limb 120 during the baseline period 402 (see FIG. 4) from the amplitudes of the early systolic component of volume pulse waves at baseline and after the stimulus. One embodiment of the arterial volume change assessment is described below in conjunction with FIG. 15.

In some embodiments, the assessment of the level of hypoxemia (or oxygen saturation) can be included in the arterial volume change assessment (block 308) and achieved by any method that is compatible with the testing procedure (e.g., based on nonpulsatile measurements of hypoxemia if a cuff 106 is used to occlude the artery). In some embodiments, the assessment of post-occlusion blood velocity or blood shear stress can be included in the arterial volume change assessment (block 308) and achieved by any method that is compatible with the testing procedure (e.g., based on Doppler measurements).

FIG. 4 is a timing diagram illustrating pressure applied to the limb 120 during the baseline testing and analysis (block 302) and after-stimulus testing and analysis (block 306) of FIG. 3 with an occlusion providing a stimulus. Prior to the procedure described in FIG. 4, a patient's blood pressure is measured to select an individualized pressure that will be applied to the limb. During blood pressure measurements, the diagnostic system 100 determines systolic, diastolic, and mean arterial pressures, which may be done in a conventional manner. Once the blood pressure measurements are performed, the individualized pressure applied to the patient's limb is determined as a percentage of diastolic, or systolic, or mean arterial pressure. It can also be determined according to a formula based on the patient's blood pressure. For instance, the pressure applied to the patient's limb may be computed as the patient's diastolic pressure minus 10 mm Hg. Standardization of the pressure applied to each patient allows the comparison of the test data among patients in whom blood pressures are different.

As an illustrative example, during a baseline period 402 (e.g., 150 seconds), the diagnostic device 102 measures the resting arterial volume pulse waves of the brachial artery 122, which are indicative of the resting diameter of the brachial artery 122. During the baseline period 402, the diagnostic system 100 commands the diagnostic device 102 to perform a series of rapid inflations 412 and deflations 414 of the cuff 106, and to collect data from the pressure sensor 230. (For the sake of clarity, only ten inflations 412 and ten deflations 414 are shown, but other numbers may be used. For the sake of clarity only one inflation/deflation cycle is labeled.) In each cycle, the cuff is rapidly inflated 412 to a pressure, such as the sub-diastolic arterial pressure, and held inflated 416 for a predetermined time (e.g., 4 to 6 seconds) and then held deflated 418 for a predetermined time (e.g., 4 to 10 seconds). In some embodiments, the diagnostic computer 104 may dynamically determine the time of the inflation 416 and the number of pulses based on the measurements. While the cuff 106 is inflated 416, the diagnostic device 102 detects a plurality of pressure oscillations (or volume pulse waves).

After the baseline period 402, the diagnostic device 102 inflates the cuff 106 to a supra-systolic pressure (e.g., systolic pressure plus 50 mm Hg) to temporarily occlude the artery 122 for an occlusion period 403 (e.g., about 300 seconds). Concurrent with the occlusion, the oxygen saturation (StO2) sensor electronics 208 controls the oxygen saturation (StO2) sensor 110 to monitor the level of hypoxemia in the limb distal to the occluding cuff.

Thereafter, the diagnostic device 102 rapidly deflates the cuff 106 (e.g., to a pressure below venous pressure, for instance, below 10 mm Hg) to allow the blood flow to rush into the limb 120 during a stimulus period 404. The pressure release of the cuff 106 creates a rapid increase in the blood flow in the artery 122, which generates shear stress on the endothelium of the brachial artery 122. The shear stress stimulates the endothelial cells to produce nitric oxide (NO), which dilates the artery 122.

Concurrent with the cuff deflation, the Doppler transducer electronics 206 controls the Doppler transducer 108 to collect data for a predetermined time (e.g., 10-180 seconds) during which time the Doppler transducer 108 measures blood velocity.

During an after-stimulus period 406, the diagnostic system 100 commands the diagnostic device 102 to perform a series of rapid inflations 422 and deflations 424 of the cuff 106, and to collect data from the pressure sensor 230 in a manner similar to that for the baseline period 402 for a predetermined time (e.g., 1-10 minutes). (For the sake of clarity, only fourteen inflations 422 and fourteen deflations 424 are shown, but other numbers may be used. For the sake of clarity only one inflation/deflation cycle is labeled.) In each series, the cuff is rapidly inflated to a pressure, and held inflated 426 for a predetermined time (e.g., 4 to 6 seconds), and then deflated 428. In some embodiments, the diagnostic computer 104 may dynamically determine the time of the inflation 426 and the number of pulses detected based on the measurements. During this time, the diagnostic computer 104 monitors the dynamics of changes in arterial volume of a limb segment (a gradual increase in pulse wave amplitude to maximum and then a gradual decrease in the pulse wave amplitude to return to a resting state).

FIG. 5 is a timing diagram illustrating amplitudes of early systolic components of pulse waves measured during the baseline period 402 and the after-stimulus period 406 of FIG. 4.

FIG. 6 is a graph illustrating correlation between the normalized increases in amplitudes of early systolic components of volume pulse waves of a segment of an arm as measured in some embodiments and the increases in diameter of a brachial artery measured via ultrasound imaging of the brachial artery. Each data point in the graph corresponds to a different patient. The stimulus in both methods was a 5-minute occlusion of the brachial artery via cuff inflation to a supra-systolic pressure. A normalization of the test results obtained with the present invention accounts for the fact the diagnostic system 100 assesses the change in the volume of substantially all arteries in the limb segment, while the ultrasound imaging visualizes only the main artery.

FIG. 7 is a timing diagram illustrating blood flow and systolic pressure after release of the occlusion in FIG. 4 during the stimulus period 404. A line 701 shows a rapid increase in blood flow followed by a decrease to normal flow. A line 702 shows the temporary drop in systolic pressure after the occlusion.

FIGS. 8a and 8b are timing diagrams illustrating measured cuff pressure oscillations of the limb 120 during one inflation/deflation cycle before occlusion (FIG. 8a) and during one cycle after occlusion (FIG. 8b) of blood vessels in the limb 120 in an expanded view. During the cuff pressure sequence, data is collected about the oscillations in the cuff pressure due to the pulsation of the brachial artery. The changes in the oscillatory amplitude (or the amplitude of a pulse wave) are related to the changes in the radius of the brachial artery, and FIG. 8b shows the pulse wave amplitude after occlusion being larger than the pulse wave amplitude before occlusion.

In some embodiments, arterial volume pulse waves are detected using an external pressure that is applied to the segment of the limb 120. In some embodiments, the externally applied pressure varies gradually between near-systolic and near-diastolic. In some embodiments, the external pressure is applied by initially applying the external pressure at a pressure near systolic, and gradually reducing the external pressure to a pressure near diastolic. In some embodiments, the external pressure is applied by initially applying the external pressure at a pressure near diastolic, gradually increasing to a pressure near systolic at a rate to allow the oscillations to be detected, and then quickly decreasing the pressure.

In some embodiments, as shown in FIGS. 4 and 9, an applied external pressure is cycled between a high level and a low level so that the arterial volume pulse waves are determined while the external pressure is at the high level. In some embodiments, the high level is below diastolic pressure and the low level is below venous pressure.

In some embodiments, the high level 416 or 426 is maintained for no more than 10 seconds in any cycle. In some embodiments, the low level 418 or 428 is maintained for at least 4 seconds in any cycle. In some embodiments, the measurements are taken over at least one cardiac cycle.

FIG. 9 is a timing diagram illustrating pressure applied to the limb 120 during the baseline testing and analysis (block 302) and after-stimulus testing and analysis (block 306) of FIG. 3 with an oral administration of nitroglycerin providing a stimulus. Because there is no occlusion period 403, the diagnostic system 100 generates a series of rapid inflations 422 and deflations 424 with an inflation state 426 and measures the volume pulse waves during the baseline period 402, the stimulus period 404 and the after-stimulus period 406.

FIG. 10 is a timing diagram illustrating amplitudes of early systolic components of pulse waves measured during the baseline period 402, the stimulus period 404 and the after-stimulus period 406 of FIG. 9.

FIG. 11 is a flow chart illustrating one embodiment of the operation of arterial volume change assessment (block 308 of FIG. 3). In response to an initiation of the diagnostic command from the user, the diagnostic computer 104 assesses change in the arterial volume of a segment of the limb 120. The diagnostic device 102 detects volume pulse waves of a segment of the limb during the baseline period 402, such as described above in conjunction with FIGS. 4-8 (or FIGS. 9-10, depending on the stimulus) (block 1102). In some embodiments, the diagnostic computer 104 commands the pneumatic module 202 to pressurize the cuff 106 to a level sufficient for the pressure detector 204 to detect volume pulse waves of a segment of the limb 120.

The diagnostic device 102 determines amplitudes of early systolic components of the detected volume pulse waves (block 1104). In some embodiments, the diagnostic computer 104 commands the pressure detector 204 to detect volume pulse waves of the segment of the limb 120. The diagnostic computer 104 analyzes the waveforms of the detected volume pulse waves and determines relevant amplitudes of the volume pulse waves for the baseline period. In one embodiment, the relevant amplitude of a pulse wave is the difference between the maximum and the minimum pressures of the pulse wave. In some embodiments, the relevant amplitude is the amplitude of the early systolic component. One embodiment for determining amplitudes of block 1104 is described below in conjunction with FIG. 12. (Blocks 1102 and 1104 may be used for the block 302 of FIG. 3).

The diagnostic device 102 applies a stimulus during the stimulus period 402 to induce a period of change in arterial volume of the segment of the limb 120 (block 1106). In some embodiments, the diagnostic computer 104 commands the pneumatic module 202 to pressurize the cuff 106 to a level sufficient for occluding the artery 122. (Block 1106 may be used for the block 306 of FIG. 3; other examples of stimuli are described above in conjunction with FIG. 1 and FIGS. 9-10).

The diagnostic device 102 detects volume pulse waves of the segment of the limb 120 during the after-stimulus period 406 to detect change in arterial volume of a limb segment, such as described above in conjunction with FIGS. 4-8 (block 1108). some embodiments, the diagnostic computer 104 commands the pneumatic module 202 to pressurize the cuff 106 to a level sufficient for the pressure detector 204 to detect volume pulse waves of a segment of the limb 120.

The diagnostic device 102 determines amplitudes of early systolic components of the detected volume pulse waves after the stimulus (block 1110). In some embodiments, the diagnostic computer 104 commands the pressure detector 204 to detect volume pulse waves of the segment of the limb 120. The diagnostic computer 104 analyzes the waveforms of the detected volume pulse waves and determines relevant amplitudes of the volume pulse waves for the baseline period. In one embodiment, the relevant amplitude of a pulse wave is the difference between the maximum and the minimum pressures of the pulse wave. In some embodiments, the relevant amplitude is the amplitude of the early systolic component. One embodiment for determining amplitudes of block 1110 is described below in conjunction with FIG. 12. (Blocks 1108 and 1110 may be used for the block 306 of FIG. 3).

The diagnostic device 102 performs an arterial volume change assessment (block 1112). In some embodiments, the diagnostic computer 104 calculates the relative change in arterial volume of the limb segment 120 during the after-stimulus time period 406 relative to the arterial volume of the limb 120 during the baseline period 402 from the amplitudes of the early systolic component of volume pulse waves at baseline and after the stimulus. In some embodiments, the diagnostic computer 104 calculates the relative change by comparing the amplitudes of early systolic component of volume pulse waves at baseline (block 1104) and after the stimulus (block 1106). (Block 1112 may be used for the block 308 of FIG. 3). One embodiment of the arterial volume change assessment is described below in conjunction with FIG. 15.

FIG. 12 is a flow chart illustrating one embodiment of an operation of determining amplitude of the arterial volume change assessments (block 308 of FIG. 3 and block 1112 of FIG. 11). The diagnostic computer 104 determines the amplitude of the early systolic component of a volume pulse wave by computing fourth derivative of the detected volume pulse wave (block 1202). The diagnostic computer 104 determines a time at which the fourth derivative crosses the zero-line for the third time (block 1204). (A third zero-line crossing 1322 of FIG. 13 below and a third zero-line crossing 1422 of FIG. 14 below.) In some embodiments, the diagnostic computer 104 may instead determine the second derivative of the detected volume pulse wave. In some embodiments, the diagnostic computer 104 may instead determine an inflection point in the volume pulse wave and use the time of occurrence of the inflection point. In some embodiments, the diagnostic computer 104 may instead use Fourier transformation of the volume pulse wave to determine the time of occurrence of the peaks of the pulse component pulse waves.

The diagnostic computer 104 determines a pressure value on the detected volume pulse wave at that time (block 1206). The diagnostic computer 104 determines a pressure value at the beginning of the volume pulse wave (block 1208). In some embodiments, the diagnostic computer 104 determines the pressure value at the beginning of the volume pulse wave by determining a minimum during the diastolic component of the pulse wave. The diagnostic computer 104 assesses the amplitude of the early systolic component of the volume pulse wave as the difference between the pressure values (block 1210).

In some embodiments, the diagnostic computer 104 may compute other orders of derivatives in block 1202, or not compute a derivative, but instead determine the inflection point corresponding to the peak of the early systolic component of the pulse wave by other methods. In other embodiments, the diagnostic computer 104 may determine the maximum amplitude of the arterial volume pulse waves.

FIG. 13 is a timing diagram illustrating a measured pulse wave for a healthy person. A pulse wave 1300 includes an early systolic component 1302 and a late systolic component 1304. (The pulse wave 1300 may include other component pulse waves, which are not shown.) The early systolic component 1302 forms an inflection point 1310 in the pulse wave 1300. Because of the amplitude and the timing of the late systolic component 1304, the maximum of the pulse wave 1300 coincides with the peak of the early systolic component 1310. A line 1320 is a fourth derivative of the pulse wave 1300 and includes a third zero-line crossing point 1322. The crossing point 1322 is used to determine the time and amplitude 1312 of the early systolic component.

During the after-stimulus period, the shape of the arterial volume pulse wave changes to a pulse wave 1350. The pulse wave 1350 includes an early systolic component 1352 and a late systolic component 1354. (The pulse wave 1350 may include other component pulse waves, which are not shown.) The early systolic component 1352 forms an inflection point 1360 in the pulse wave 1350. During the after stimulus period, the amplitude and the timing of the late systolic component 1352 change slightly and the maximum 1366 of the pulse wave 1350 no longer coincides with the peak of the early systolic component 1360. Yet, the amplitude 1362 of the early systolic component 1352 and the amplitude (distance 1362 plus the distance 1364) of the maximum 1366 of the pulse wave 1350 differ slightly.

FIG. 14 is a timing diagram illustrating a measured pulse wave for a patient with cardiovascular disease. A pulse wave 1400 includes an early systolic component 1402 and a late systolic component 1404. (The pulse wave 1400 may include other component pulse waves, which are not shown.) The early systolic component 1402 forms an inflection point 1410 in the pulse wave 1400. Because of the amplitude and the timing of the late systolic component 1404, the maximum of the pulse wave 1400 coincides with the peak of the early systolic component 1410. A line 1420 is a fourth derivative of the pulse wave 1400 and includes a third zero-line crossing point 1422. The crossing point 1422 is used to determine the time and amplitude 1412 of the early systolic component.

During the after-stimulus period, the shape of the arterial volume pulse wave changes to a pulse wave 1450. A pulse wave 1450 includes an early systolic component 1452 and a late systolic component 1454. (The pulse wave 1450 may include other component pulse waves, which are not shown.) The early systolic component 1452 forms an inflection point 1460 in the pulse wave 1450. During the after stimulus period the amplitude and the timing of the late systolic component change significantly and the maximum 1466 of the pulse wave 1450 no longer coincides with the peak of the early systolic component 1460. The amplitude 1462 of the early systolic component 1452 and the amplitude (distance 1462 plus the distance 1464) of the maximum 1466 of the pulse wave 1450 differ significantly.

The diagnostic system 100 may use the differences in the pulse wave characteristics of FIGS. 13-14 to compute arterial indexes (for instance, the augmentation index) to assess the cardiovascular status of the patient.

FIG. 15 is a flow chart illustrating one embodiment of an operation of determining changes in arterial volume of the operations of FIGS. 3 and 11. The diagnostic computer 104 determines average pulse wave amplitude per each inflation/deflation cycle over the measurement period and obtains a graph such as the graph described above in conjunction with FIG. 5.

The diagnostic computer 104 calculates an average (AVGbaseline) of the calculated average amplitudes of the early systolic components of pulse wave measured during the baseline 402 (block 1502). For the after-stimulus period 406, the diagnostic computer 104 calculates a curve that fits the after-stimulus data of the early systolic components of pulse wave measured during the after-stimulus 406 (block 1504), using for example, a fourth-order polynomial function. The diagnostic computer 104 calculates a maximum (MAXafter) of the fitted curve of the after-stimulus data (block 1506). The diagnostic computer 104 calculates a time from the end of the occlusion (or other stimulus) to the maximum of the fitted curve of the after-stimulus data (block 1508). The diagnostic computer 104 calculates a relative amplitude change from the baseline to the maximum of the fitted curve of the after-stimulus data (block 1510).

The diagnostic computer 104 calculates relative change in arterial volume ΔV (block 1512) as follows:
ΔV=[(MAXafter−AVGbaseline)/AVGbaseline]

The diagnostic computer 104 calculates relative change in arterial radius as follows (block 1512):
ΔR=[(ΔV+1)1/2−1],
The relative change in ΔR is defined as follows:
ΔR=[(Rafter−Rbaseline)/Rbaseline],
where Rafter is the maximum after-stimulus radius of the artery and Rbaseline is the arterial radius at baseline.

In some embodiments, the diagnostic computer 104 may compute an area under the fitted curve for the after-stimulus data, in addition to or instead of the determination of the maximum of the fitted curve of block 1506. In some embodiments, the diagnostic computer 104 determines the area under the curve by integrating the fitted polynomial function of block 1504 from the time the stimulus ends to either the time when the measured amplitude returns to the baseline or to the end of the test. In some embodiments, the diagnostic computer 104 extrapolates the fitted curve of block 1504 to the time at which the measured amplitude returns to baseline. In some embodiments, the diagnostic computer 104 computes other parameters (e.g., the width at half-height) from the fitted curve of block 1504 to calculate the relative change in arterial volume.

The diagnostic computer 104 may provide any or all of the raw data and processed data to a doctor or clinical researcher via a display, paper or other manners well known to those skilled in the art. In some embodiments, the diagnostic computer 104 provides a doctor processed data such as 1) relative % change in arterial volume of a limb segment after a stimulus (for example, after 5 min cuff occlusion, the arterial volume changed by 57%) as a reflection of the ability of the arteries to dilate in response to the stimulus; 2) computed relative maximum % change in the radius of the artery after the stimulus; time to maximum change in arterial volume (for instance, 72 sec); 4) area under the curve; and 5) pulse wave characteristics (time difference between the peaks of early and late systolic waves, augmentation index, etc.) as indicators of arterial stiffness. In some embodiments, the diagnostic computer 104 provides a doctor raw data, such as detected volume pulse waves in each inflation/deflation cycles.

Although the diagnostic system 100 is described as including one cuff 106, other numbers of cuffs 106 may be used. In some embodiments, the diagnostic system 100 includes two cuffs 106. One cuff 106 is disposed on the limb 120 and occludes the artery 122, and the other cuff 106 is disposed on the limb 120 distal to the first cuff 106, and detects the pressure oscillations. Alternatively, one cuff 106 is disposed on the limb 120 and detects the pressure in the artery 122, and the other cuff 106 is disposed on the limb 120 distal to the first cuff 106, and occludes the artery 122.

Reference in the specification to “some embodiments” means that a particular feature, structure, or characteristic described in connection with the embodiments is included in at least one embodiment of the invention. The appearances of the phrase “in some embodiments” in various places in the specification are not necessarily all referring to the same embodiment.

Some portions of the detailed description that follows are presented in terms of algorithms and symbolic representations of operations on data bits within a computer memory. These algorithmic descriptions and representations are the means used by those skilled in the data processing arts to most effectively convey the substance of their work to others skilled in the art. An algorithm is here, and generally, conceived to be a self-consistent sequence of steps (instructions) leading to a desired result. The steps are those requiring physical manipulations of physical quantities. Usually, though not necessarily, these quantities take the form of electrical, magnetic or optical signals capable of being stored, transferred, combined, compared and otherwise manipulated. It is convenient at times, principally for reasons of common usage, to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. Furthermore, it is also convenient at times, to refer to certain arrangements of steps requiring physical manipulations of physical quantities as modules or code devices, without loss of generality.

However, all of these and similar terms are to be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities. Unless specifically stated otherwise as apparent from the following discussion, it is appreciated that throughout the description, discussions utilizing terms such as “processing” or “computing” or “calculating” or “determining” or “displaying” or “determining” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system memories or registers or other such information storage, transmission or display devices.

Certain aspects of the present invention include process steps and instructions described herein in the form of an algorithm. It should be noted that the process steps and instructions of the present invention could be embodied in software, firmware or hardware, and when embodied in software, could be downloaded to reside on and be operated from different platforms used by a variety of operating systems.

The present invention also relates to an apparatus for performing the operations herein. This apparatus may be specially constructed for the required purposes, or it may comprise a general-purpose computer selectively activated or reconfigured by a computer program stored in the computer. Such a computer program may be stored in a computer readable storage medium, such as, but is not limited to, any type of disk including floppy disks, optical disks, CD-ROMs, magnetic-optical disks, read-only memories (ROMs), random access memories (RAMs), EPROMs, EEPROMs, magnetic or optical cards, application specific integrated circuits (ASICs), or any type of media suitable for storing electronic instructions, and each coupled to a computer system bus. Furthermore, the computers referred to in the specification may include a single processor or may be architectures employing multiple processor designs for increased computing capability.

The algorithms and displays presented herein are not inherently related to any particular computer or other apparatus. Various general-purpose systems may also be used with programs in accordance with the teachings herein, or it may prove convenient to construct more specialized apparatus to perform the required method steps. The required structure for a variety of these systems will appear from the description below. In addition, the present invention is not described with reference to any particular programming language. It will be appreciated that a variety of programming languages may be used to implement the teachings of the present invention as described herein, and any references below to specific languages are provided for disclosure of enablement and best mode of the present invention.

While particular embodiments and applications of the present invention have been illustrated and described herein, it is to be understood that the invention is not limited to the precise construction and components disclosed herein and that various modifications, changes, and variations may be made in the arrangement, operation, and details of the methods and apparatuses of the present invention without departing from the spirit and scope of the invention as it is defined in the appended claims.

Claims

1. A diagnostic system for assessing a change in arterial volume of a limb segment of a mammal, the diagnostic system comprising:

a sensor configured to detect a baseline volume pulse wave of a limb segment during a baseline period and an after-stimulus volume pulse wave of the limb segment during an after-stimulus period, the sensor being configured to operatively engage the limb segment at a position proximal from individual digits of the limb; wherein the sensor includes a pressure sensor configured to sense a pressure of an inflatable cuff associated with the limb segment; and wherein, when inflated above about systolic pressure, the inflatable cuff substantially occludes an artery of the limb segment; and
a processor operatively coupled to the sensor, the processor being configured to determine an amplitude of an early systolic component of the baseline volume pulse wave, an amplitude of an early systolic component of the after-stimulus volume pulse wave, and a change in arterial volume of the limb segment from the baseline period to the after-stimulus period using the amplitude of the early systolic component of the baseline volume pulse wave and the amplitude of the early systolic component of the after-stimulus volume pulse wave; and wherein the processor is configured to control the cuff to apply, in series, an external pressure to the limb segment at about a mean arterial pressure of the limb, the external pressure being applied during the baseline period and the after-stimulus period.

2. The diagnostic system of claim 1, wherein the processor is configured to control the cuff to apply an external pressure to the limb segment at a pressure level which allows blood flow through the artery to produce the baseline volume pulse wave and at the after-stimulus volume pulse wave.

3. The diagnostic system of claim 1,

wherein the processor is configured to control the cuff to apply an external pressure to the limb segment as a gradually varying pressure between near-systolic and near-diastolic, and
wherein the processor is configured to control the sensor to detect the baseline volume pulse wave and at the after-stimulus volume pulse wave while the external pressure is between systolic and diastolic.

4. The diagnostic system of claim 3, wherein the processor is configured to control the cuff to apply the external pressure to the limb segment at a pressure near systolic, and gradually reducing the pressure to near diastolic.

5. The diagnostic system of claim 3, wherein the processor is configured to control the cuff to apply the external pressure to the limb segment at a pressure near diastolic, and gradually increasing to the pressure to near systolic.

6. The diagnostic system of claim 1,

wherein the processor is configured to control the cuff to cycle an external pressure applied to the limb segment between a high level and a low level,
wherein the processor is configured to determine the amplitude of the early systolic component of the baseline volume pulse wave and the amplitude of the early systolic component of the after-stimulus volume pulse wave while the external pressure is at the high level.

7. The diagnostic system of claim 6, wherein the high level is near mean arterial pressure and the low level is below venous pressure.

8. The diagnostic system of claim 6, wherein the high level is below diastolic pressure and the low level is below venous pressure.

Referenced Cited
U.S. Patent Documents
3807389 April 1974 Miller et al.
3903872 September 1975 Link
3980075 September 14, 1976 Heule
4009709 March 1, 1977 Link et al.
4074711 February 21, 1978 Link et al.
4163447 August 7, 1979 Orr
4195643 April 1, 1980 Pratt, Jr.
4432374 February 21, 1984 Osanai
4562843 January 7, 1986 Djordjevich et al.
4566463 January 28, 1986 Taniguchi et al.
4646754 March 3, 1987 Seale
4669485 June 2, 1987 Russell
4677983 July 7, 1987 Yamaguchi et al.
4718426 January 12, 1988 Russell
4718427 January 12, 1988 Russell
4718428 January 12, 1988 Russell
4771792 September 20, 1988 Seale
4798211 January 17, 1989 Goor et al.
4821735 April 18, 1989 Goor et al.
4846189 July 11, 1989 Sun
4850371 July 25, 1989 Broadhurst et al.
4880013 November 14, 1989 Chio
4966141 October 30, 1990 Bacaner et al.
4979110 December 18, 1990 Albrecht et al.
4986277 January 22, 1991 Sackner
4993422 February 19, 1991 Hon et al.
5025792 June 25, 1991 Hon et al.
5040540 August 20, 1991 Sackner
5043576 August 27, 1991 Broadhurst et al.
5048533 September 17, 1991 Muz
5054494 October 8, 1991 Lazzaro et al.
5099852 March 31, 1992 Meister et al.
5119824 June 9, 1992 Niwa
5127408 July 7, 1992 Parsons et al.
5140990 August 25, 1992 Jones et al.
5152297 October 6, 1992 Meister et al.
5161531 November 10, 1992 Parsons et al.
5162991 November 10, 1992 Chio
5241963 September 7, 1993 Shankar
5241964 September 7, 1993 McQuilkin
5269310 December 14, 1993 Jones et al.
5271399 December 21, 1993 Listerud et al.
5297556 March 29, 1994 Shankar
5303711 April 19, 1994 Sciarra
5343867 September 6, 1994 Shankar
5379774 January 10, 1995 Nishimura et al.
5423322 June 13, 1995 Clark et al.
5447163 September 5, 1995 Apple
5511546 April 30, 1996 Hon
5533511 July 9, 1996 Kaspari et al.
5685989 November 11, 1997 Krivitski et al.
5758652 June 2, 1998 Nikolic
5810734 September 22, 1998 Caro et al.
5830131 November 3, 1998 Caro et al.
5833602 November 10, 1998 Osemwota
5876347 March 2, 1999 Chesney et al.
5906581 May 25, 1999 Tsuda
5935066 August 10, 1999 Harris
5980464 November 9, 1999 Tsuda
6010457 January 4, 2000 O'Rourke
6015393 January 18, 2000 Hovland et al.
6027452 February 22, 2000 Flaherty et al.
6045509 April 4, 2000 Caro et al.
6048318 April 11, 2000 Chesney et al.
6120459 September 19, 2000 Nitzan et al.
6152881 November 28, 2000 Raines et al.
6162181 December 19, 2000 Hynson et al.
6171242 January 9, 2001 Amano et al.
6210591 April 3, 2001 Krivitski
6241680 June 5, 2001 Miwa
6290651 September 18, 2001 Chesney et al.
6309359 October 30, 2001 Whitt et al.
6319205 November 20, 2001 Goor et al.
6322515 November 27, 2001 Goor et al.
6331159 December 18, 2001 Amano et al.
6331161 December 18, 2001 Chesney et al.
6338719 January 15, 2002 Drzewiecki et al.
6440080 August 27, 2002 Booth et al.
6445945 September 3, 2002 Arsenault
6461305 October 8, 2002 Schnall
6482163 November 19, 2002 Oka et al.
6488633 December 3, 2002 Schnall
6488663 December 3, 2002 Steg
6491647 December 10, 2002 Bridger et al.
6517495 February 11, 2003 Hersh
6554774 April 29, 2003 Miele
6585659 July 1, 2003 Chesney et al.
6592528 July 15, 2003 Amano
6616613 September 9, 2003 Goodman
6623431 September 23, 2003 Sakuma et al.
6623434 September 23, 2003 Chesney et al.
6626840 September 30, 2003 Drzewiecki et al.
6629343 October 7, 2003 Chesney et al.
6632181 October 14, 2003 Flaherty et al.
6654628 November 25, 2003 Silber et al.
6662130 December 9, 2003 Peel, III et al.
6719704 April 13, 2004 Narimatsu et al.
6733461 May 11, 2004 Bratteli
6746407 June 8, 2004 Steuer et al.
6749567 June 15, 2004 Davis et al.
6757554 June 29, 2004 Rubinstein et al.
6804543 October 12, 2004 Miller et al.
6868739 March 22, 2005 Krivitski et al.
6884221 April 26, 2005 Narimatsu et al.
6896660 May 24, 2005 Jelliffe et al.
6905470 June 14, 2005 Lee et al.
6908436 June 21, 2005 Chowienczyk et al.
6915154 July 5, 2005 Docherty et al.
6916289 July 12, 2005 Schnall
6937882 August 30, 2005 Steuer et al.
6939304 September 6, 2005 Schnall et al.
6939305 September 6, 2005 Flaherty et al.
6987993 January 17, 2006 Steuer et al.
6994675 February 7, 2006 Sharrock
7022084 April 4, 2006 Ogura
7024234 April 4, 2006 Margulies et al.
7041060 May 9, 2006 Flaherty et al.
7048691 May 23, 2006 Miele et al.
7056291 June 6, 2006 Yokozeki et al.
7070569 July 4, 2006 Heinonen et al.
7074183 July 11, 2006 Castellanos
7077809 July 18, 2006 Wu et al.
7121150 October 17, 2006 Krivitski et al.
7131949 November 7, 2006 Hayano et al.
7204798 April 17, 2007 Zdeblick et al.
7214192 May 8, 2007 Poliac et al.
7244225 July 17, 2007 Loeb et al.
7250031 July 31, 2007 Hayano et al.
7264594 September 4, 2007 Shimazu et al.
7291112 November 6, 2007 Martin et al.
7291113 November 6, 2007 Satoh et al.
7297280 November 20, 2007 Krivitski et al.
7318804 January 15, 2008 Weitzel et al.
7374541 May 20, 2008 Amitzur et al.
7621877 November 24, 2009 Schnall
7806831 October 5, 2010 Lavie et al.
20010025151 September 27, 2001 Kimball et al.
20020013533 January 31, 2002 Oka et al.
20020062086 May 23, 2002 Miele et al.
20020065471 May 30, 2002 Amano et al.
20020072681 June 13, 2002 Schnali
20020111554 August 15, 2002 Drzewiecki et al.
20020183599 December 5, 2002 Castellanos
20030004423 January 2, 2003 Lavie et al.
20030032885 February 13, 2003 Rubinstein et al.
20030036685 February 20, 2003 Goodman
20030040675 February 27, 2003 Sharrock
20030060690 March 27, 2003 Jelliffe et al.
20030065270 April 3, 2003 Raines et al.
20030191395 October 9, 2003 Bowman et al.
20030212336 November 13, 2003 Lee et al.
20030216652 November 20, 2003 Narimatsu et al.
20030229288 December 11, 2003 Chowienczyk et al.
20030236464 December 25, 2003 Narimatsu et al.
20040092832 May 13, 2004 Schnall et al.
20040116787 June 17, 2004 Schnall
20040127800 July 1, 2004 Kimball et al.
20040167413 August 26, 2004 Bratteli
20040210145 October 21, 2004 Satoh et al.
20040215085 October 28, 2004 Schnall
20040215093 October 28, 2004 Rubenstein et al.
20040230125 November 18, 2004 Amano et al.
20040254483 December 16, 2004 Zdeblick et al.
20040254485 December 16, 2004 Wu et al.
20040267141 December 30, 2004 Amano et al.
20050004476 January 6, 2005 Payvar et al.
20050020891 January 27, 2005 Rubinstein et al.
20050020928 January 27, 2005 Arsenault
20050038346 February 17, 2005 Miele
20050043608 February 24, 2005 Haj-Yousef
20050070805 March 31, 2005 Dafni
20050075531 April 7, 2005 Loeb et al.
20050085712 April 21, 2005 Rapoport
20050107710 May 19, 2005 Nakayama
20050113652 May 26, 2005 Stark et al.
20050143633 June 30, 2005 Jelliffe et al.
20050171443 August 4, 2005 Gorenberg et al.
20050182434 August 18, 2005 Docherty et al.
20050228303 October 13, 2005 Hayano et al.
20050267381 December 1, 2005 Benditt et al.
20060009700 January 12, 2006 Brumfield et al.
20060015032 January 19, 2006 Gordon
20060052713 March 9, 2006 Poliac et al.
20060064024 March 23, 2006 Schnall
20060079791 April 13, 2006 Letremy et al.
20060104824 May 18, 2006 Schnall
20060122489 June 8, 2006 Kato et al.
20060149152 July 6, 2006 Amitzur et al.
20060178585 August 10, 2006 Sharrock
20060206030 September 14, 2006 Flaherty et al.
20060206032 September 14, 2006 Miele et al.
20060217614 September 28, 2006 Takala et al.
20060217615 September 28, 2006 Huiku et al.
20060229488 October 12, 2006 Ayre et al.
20060229506 October 12, 2006 Castellanos
20060229519 October 12, 2006 Fujiwara et al.
20060241459 October 26, 2006 Tai
20060247538 November 2, 2006 Davis
20060258946 November 16, 2006 Hayano et al.
20060264755 November 23, 2006 Maltz et al.
20060287600 December 21, 2006 McEowen
20070021673 January 25, 2007 Arbel et al.
20070021683 January 25, 2007 Benditt et al.
20070055163 March 8, 2007 Asada et al.
20070078351 April 5, 2007 Fujita et al.
20070106162 May 10, 2007 Illyes et al.
20070118045 May 24, 2007 Naghavi et al.
20070161914 July 12, 2007 Zdeblick et al.
20070173727 July 26, 2007 Naghavi et al.
20070225606 September 27, 2007 Naghavi et al.
20070270720 November 22, 2007 Fry
20080004511 January 3, 2008 Rubenstein et al.
20080015434 January 17, 2008 Rubenstein et al.
20080027298 January 31, 2008 Blanco et al.
20080027330 January 31, 2008 Naghavi et al.
20080033307 February 7, 2008 Baudoin et al.
20080039731 February 14, 2008 McCombie et al.
20080077024 March 27, 2008 Schnall
20080139949 June 12, 2008 Caldarone et al.
Foreign Patent Documents
102004016376 October 2005 DE
0197302 October 1986 EP
0244264 November 1987 EP
0262778 April 1988 EP
0347101 December 1989 EP
0443267 August 1991 EP
0694283 January 1996 EP
0716829 June 1996 EP
0818175 January 1998 EP
0997102 May 2000 EP
1175864 January 2002 EP
1360929 November 2003 EP
1362549 November 2003 EP
1374760 January 2004 EP
1584289 October 2005 EP
1618840 January 2006 EP
1704818 September 2006 EP
1743572 January 2007 EP
1769748 April 2007 EP
1849408 October 2007 EP
1852061 November 2007 EP
1852063 November 2007 EP
1992282 November 2008 EP
120109 December 2002 IL
120881 December 2002 IL
151437 September 2007 IL
154833 September 2007 IL
5305061 November 1993 JP
9173307 July 1997 JP
2004129979 April 2004 JP
2006102252 April 2006 JP
2006115979 May 2006 JP
2006181261 July 2006 JP
2220653 January 2004 RU
2004102316 July 2005 RU
2302196 July 2007 RU
8604801 August 1986 WO
8909017 October 1989 WO
9001895 March 1990 WO
9002512 March 1990 WO
9207508 May 1992 WO
9222239 December 1992 WO
9305704 April 1993 WO
9518564 July 1995 WO
9709927 March 1997 WO
9712545 April 1997 WO
9714356 April 1997 WO
9749328 December 1997 WO
9804182 February 1998 WO
9842255 October 1998 WO
9934724 July 1999 WO
9939634 August 1999 WO
9963884 December 1999 WO
0017615 March 2000 WO
0032103 June 2000 WO
0057776 October 2000 WO
0059372 October 2000 WO
0074551 December 2000 WO
0074563 December 2000 WO
0122870 April 2001 WO
0164101 September 2001 WO
0170303 September 2001 WO
0195798 December 2001 WO
0200107 January 2002 WO
0205726 January 2002 WO
0234105 May 2002 WO
02034105 May 2002 WO
02080752 October 2002 WO
02089668 November 2002 WO
02094085 November 2002 WO
02099600 December 2002 WO
03051193 June 2003 WO
03086169 October 2003 WO
2004006748 January 2004 WO
2004021878 March 2004 WO
2004041079 May 2004 WO
2004052196 June 2004 WO
2004066817 August 2004 WO
2005006975 January 2005 WO
2005028029 March 2005 WO
2005030038 April 2005 WO
2005092178 October 2005 WO
2005110051 November 2005 WO
2006024871 March 2006 WO
2006034542 June 2006 WO
2006102511 September 2006 WO
2007024777 March 2007 WO
2009144598 December 2009 WO
2009144721 December 2009 WO
2010089745 August 2010 WO
Other references
  • International Search Report and Written Opinion issued on Jul. 6, 2010 regarding PCT/US2010/033907 with a filing date on May 6, 2010.
  • Tsui, et al., Arterial pulse waveform analysis by the probability distribution of amplitude, 2007, vol. 28, No. 8, Physiological Measurement—attached as reference to International Search Report and Written Opinion issued on Jul. 6, 2010 regarding PCT/US2010/033907.
  • Semkin, ND, Diagnosis of vascular endothelial function in patients with cardiovascular disease Methodological guidelines, 2004, 17 pp., Samara State Aerospace University.
  • Extended European Search Report, from application EP 06784054, issued by the European Patent Office in Berlin, Germany, with a mailing date of Aug. 6, 2009.
  • International Preliminary Report on Patentability, from PCT/RU2006/000158 with an international filing date of Apr. 3, 2006, prepared by the International Bureau of WIPO and mailed on Dec. 10, 2008.
Patent History
Patent number: 8657755
Type: Grant
Filed: Oct 4, 2011
Date of Patent: Feb 25, 2014
Patent Publication Number: 20120259236
Assignee: Angiologix, Inc. (Ann Arbor, MI)
Inventors: Alexander S. Parfenov (Moscow), Maria A. Parfenova (Mountain View, CA), Nikolay V. Konstantinov (Moscow)
Primary Examiner: Patricia Mallari
Assistant Examiner: Christian Jang
Application Number: 13/252,245
Classifications
Current U.S. Class: By Detecting Volume Of Body Portion (600/507); Detecting Blood Vessel Pulsation (600/500)
International Classification: A61B 5/02 (20060101);